Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 259 entries
Sorted by: Best Match Show Resources per page
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.

Microbiology spectrum

Valcourt EJ, Manguiat K, Robinson A, Lin YC, Abe KT, Mubareka S, Shigayeva A, Zhong Z, Girardin RC, DuPuis A, Payne A, McDonough K, Wang Z, Gasser R, Laumaea A, Benlarbi M, Richard J, Prévost J, Anand SP, Dimitrova K, Phillipson C, McGeer A, Gingras AC, Liang C, Petric M, Sekirov I, Morshed M, Finzi A, Drebot M, Wood H.
PMID: 34787495
Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17.

The evaluation of humoral protective immunity against SARS-CoV-2 remains crucial in understanding both natural immunity and protective immunity conferred by the several vaccines implemented in the fight against COVID-19. The reference standard for the quantification of antibodies capable of...

Cite
Valcourt EJ, Manguiat K, Robinson A, et al. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays. Microbiol Spectr. 2021;9(3):e0088621doi: 10.1128/Spectrum.00886-21.
Valcourt, E. J., Manguiat, K., Robinson, A., Lin, Y. C., Abe, K. T., Mubareka, S., Shigayeva, A., Zhong, Z., Girardin, R. C., DuPuis, A., Payne, A., McDonough, K., Wang, Z., Gasser, R., Laumaea, A., Benlarbi, M., Richard, J., Prévost, J., Anand, S. P., Dimitrova, K., Phillipson, C., McGeer, A., Gingras, A. C., Liang, C., Petric, M., Sekirov, I., Morshed, M., Finzi, A., Drebot, M., & Wood, H. (2021). Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays. Microbiology spectrum, 9(3), e0088621. https://doi.org/10.1128/Spectrum.00886-21
Valcourt, Emelissa J, et al. "Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays." Microbiology spectrum vol. 9,3 (2021): e0088621. doi: https://doi.org/10.1128/Spectrum.00886-21
Valcourt EJ, Manguiat K, Robinson A, Lin YC, Abe KT, Mubareka S, Shigayeva A, Zhong Z, Girardin RC, DuPuis A, Payne A, McDonough K, Wang Z, Gasser R, Laumaea A, Benlarbi M, Richard J, Prévost J, Anand SP, Dimitrova K, Phillipson C, McGeer A, Gingras AC, Liang C, Petric M, Sekirov I, Morshed M, Finzi A, Drebot M, Wood H. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays. Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17. PMID: 34787495; PMCID: PMC8597631.
Copy Download .nbib Format: NLM
Food-Drug Interactions with Fruit Juices.

Foods (Basel, Switzerland)

Petric Z, Žuntar I, Putnik P, Bursać Kovačević D.
PMID: 33374399
Foods. 2020 Dec 24;10(1). doi: 10.3390/foods10010033.

Fruit juices contain a large number of phytochemicals that, in combination with certain drugs, can cause food-drug interactions that can be clinically significant and lead to adverse events. The mechanisms behind such interactions are in most cases related to...

Cite
Petric Z, Žuntar I, Putnik P, et al. Food-Drug Interactions with Fruit Juices. Foods. 2020;10(1)doi: 10.3390/foods10010033.
Petric, Z., Žuntar, I., Putnik, P., & Bursać Kovačević, D. (2020). Food-Drug Interactions with Fruit Juices. Foods (Basel, Switzerland), 10(1), . https://doi.org/10.3390/foods10010033
Petric, Zvonimir, et al. "Food-Drug Interactions with Fruit Juices." Foods (Basel, Switzerland) vol. 10,1 (2020). doi: https://doi.org/10.3390/foods10010033
Petric Z, Žuntar I, Putnik P, Bursać Kovačević D. Food-Drug Interactions with Fruit Juices. Foods. 2020 Dec 24;10(1). doi: 10.3390/foods10010033. PMID: 33374399; PMCID: PMC7823305.
Copy Download .nbib Format: NLM
HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.

Cancer letters

Petri BJ, Piell KM, South Whitt GC, Wilt AE, Poulton CC, Lehman NL, Clem BF, Nystoriak MA, Wysoczynski M, Klinge CM.
PMID: 34273466
Cancer Lett. 2021 Oct 10;518:152-168. doi: 10.1016/j.canlet.2021.07.015. Epub 2021 Jul 14.

Despite new combination therapies improving survival of breast cancer patients with estrogen receptor α (ER+) tumors, the molecular mechanisms for endocrine-resistant disease remain unresolved. Previously we demonstrated that expression of the RNA binding protein and N6-methyladenosine (m6A) reader HNRNPA2B1...

Cite
Petri BJ, Piell KM, South Whitt GC, et al. HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. Cancer Lett. 2021;518:152-168doi: 10.1016/j.canlet.2021.07.015.
Petri, B. J., Piell, K. M., South Whitt, G. C., Wilt, A. E., Poulton, C. C., Lehman, N. L., Clem, B. F., Nystoriak, M. A., Wysoczynski, M., & Klinge, C. M. (2021). HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. Cancer letters, 518152-168. https://doi.org/10.1016/j.canlet.2021.07.015
Petri, Belinda J, et al. "HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells." Cancer letters vol. 518 (2021): 152-168. doi: https://doi.org/10.1016/j.canlet.2021.07.015
Petri BJ, Piell KM, South Whitt GC, Wilt AE, Poulton CC, Lehman NL, Clem BF, Nystoriak MA, Wysoczynski M, Klinge CM. HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. Cancer Lett. 2021 Oct 10;518:152-168. doi: 10.1016/j.canlet.2021.07.015. Epub 2021 Jul 14. PMID: 34273466; PMCID: PMC8358706.
Copy Download .nbib Format: NLM
Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis.

Orphanet journal of rare diseases

Connolly MP, Panda S, Patris J, Hazenberg BPC.
PMID: 31533773
Orphanet J Rare Dis. 2019 Sep 18;14(1):220. doi: 10.1186/s13023-019-1199-x.

BACKGROUND: A wide range of rare diseases can have fiscal impacts on government finances that extend beyond expected healthcare costs. Conditions preventing people from achieving national lifetime work averages will influence lifetime taxes paid and increase the likelihood of...

Cite
Connolly MP, Panda S, Patris J, et al. Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet J Rare Dis. 2019;14(1):220doi: 10.1186/s13023-019-1199-x.
Connolly, M. P., Panda, S., Patris, J., & Hazenberg, B. P. C. (2019). Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet journal of rare diseases, 14(1), 220. https://doi.org/10.1186/s13023-019-1199-x
Connolly, Mark P, et al. "Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis." Orphanet journal of rare diseases vol. 14,1 (2019): 220. doi: https://doi.org/10.1186/s13023-019-1199-x
Connolly MP, Panda S, Patris J, Hazenberg BPC. Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet J Rare Dis. 2019 Sep 18;14(1):220. doi: 10.1186/s13023-019-1199-x. PMID: 31533773; PMCID: PMC6751602.
Copy Download .nbib Format: NLM
Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing.

Analytical chemistry

Petri J, Johannsmann D.
PMID: 30576109
Anal Chem. 2019 Jan 15;91(2):1595-1602. doi: 10.1021/acs.analchem.8b05037. Epub 2019 Jan 04.

The photoinduced curing of a light-sensitive varnish was followed, based on a change of the film's shear modulus, G, as determined with a quartz crystal microbalance (QCM). The film thickness was in the range of a few hundred nanometers....

Cite
Petri J, Johannsmann D. Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing. Anal Chem. 2019;91(2):1595-1602doi: 10.1021/acs.analchem.8b05037.
Petri, J., & Johannsmann, D. (2019). Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing. Analytical chemistry, 91(2), 1595-1602. https://doi.org/10.1021/acs.analchem.8b05037
Petri, Judith, and Johannsmann, Diethelm. "Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing." Analytical chemistry vol. 91,2 (2019): 1595-1602. doi: https://doi.org/10.1021/acs.analchem.8b05037
Petri J, Johannsmann D. Determination of the Shear Modulus of Thin Polymer Films with a Quartz Crystal Microbalance: Application to UV-Curing. Anal Chem. 2019 Jan 15;91(2):1595-1602. doi: 10.1021/acs.analchem.8b05037. Epub 2019 Jan 04. PMID: 30576109.
Copy Download .nbib Format: NLM
Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans.

Psychological medicine

Metrik J, Stevens AK, Gunn RL, Borsari B, Jackson KM.
PMID: 32546286
Psychol Med. 2020 Jun 17;1-11. doi: 10.1017/S003329172000197X. Epub 2020 Jun 17.

BACKGROUND: Posttraumatic stress disorder (PTSD) is the most highly co-occurring psychiatric disorder among veterans with cannabis use disorder (CUD). Despite some evidence that cannabis use prospectively exacerbates the course of PTSD, which in turn increases the risk for CUD,...

Cite
Metrik J, Stevens AK, Gunn RL, et al. Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans. Psychol Med. 2020;1-11doi: 10.1017/S003329172000197X.
Metrik, J., Stevens, A. K., Gunn, R. L., Borsari, B., & Jackson, K. M. (2020). Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans. Psychological medicine, 1-11. https://doi.org/10.1017/S003329172000197X
Metrik, Jane, et al. "Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans." Psychological medicine vol. (2020): 1-11. doi: https://doi.org/10.1017/S003329172000197X
Metrik J, Stevens AK, Gunn RL, Borsari B, Jackson KM. Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans. Psychol Med. 2020 Jun 17;1-11. doi: 10.1017/S003329172000197X. Epub 2020 Jun 17. PMID: 32546286.
Copy Download .nbib Format: NLM
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.

Life (Basel, Switzerland)

Rusic D, Vilovic M, Bukic J, Leskur D, Seselja Perisin A, Kumric M, Martinovic D, Petric A, Modun D, Bozic J.
PMID: 33801799
Life (Basel). 2021 Mar 10;11(3). doi: 10.3390/life11030220.

The net effect of the coronavirus disease 2019 (COVID-19) pandemic and the response to it on the emergence of antimicrobial resistance is yet unknown. Positive impacts on the spread of multiresistant pathogens and infections in general may be observed...

Cite
Rusic D, Vilovic M, Bukic J, et al. Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks. Life (Basel). 2021;11(3)doi: 10.3390/life11030220.
Rusic, D., Vilovic, M., Bukic, J., Leskur, D., Seselja Perisin, A., Kumric, M., Martinovic, D., Petric, A., Modun, D., & Bozic, J. (2021). Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks. Life (Basel, Switzerland), 11(3), . https://doi.org/10.3390/life11030220
Rusic, Doris, et al. "Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks." Life (Basel, Switzerland) vol. 11,3 (2021). doi: https://doi.org/10.3390/life11030220
Rusic D, Vilovic M, Bukic J, Leskur D, Seselja Perisin A, Kumric M, Martinovic D, Petric A, Modun D, Bozic J. Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks. Life (Basel). 2021 Mar 10;11(3). doi: 10.3390/life11030220. PMID: 33801799; PMCID: PMC8000815.
Copy Download .nbib Format: NLM
Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity.

Frontiers in neurology

Blair JC, Barrett MJ, Patrie J, Flanigan JL, Sperling SA, Elias WJ, Druzgal TJ.
PMID: 31920949
Front Neurol. 2019 Dec 18;10:1329. doi: 10.3389/fneur.2019.01329. eCollection 2019.

Models which assess the progression of Lewy pathology in Parkinson's disease have proposed ascending spread in a caudal-rostral pattern.

Cite
Blair JC, Barrett MJ, Patrie J, et al. Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity. Front Neurol. 2019;10:1329doi: 10.3389/fneur.2019.01329.
Blair, J. C., Barrett, M. J., Patrie, J., Flanigan, J. L., Sperling, S. A., Elias, W. J., & Druzgal, T. J. (2019). Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity. Frontiers in neurology, 101329. https://doi.org/10.3389/fneur.2019.01329
Blair, Jamie C, et al. "Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity." Frontiers in neurology vol. 10 (2019): 1329. doi: https://doi.org/10.3389/fneur.2019.01329
Blair JC, Barrett MJ, Patrie J, Flanigan JL, Sperling SA, Elias WJ, Druzgal TJ. Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across Severity. Front Neurol. 2019 Dec 18;10:1329. doi: 10.3389/fneur.2019.01329. eCollection 2019. PMID: 31920949; PMCID: PMC6930693.
Copy Download .nbib Format: NLM
Autophagy: A promising target for triple negative breast cancers.

Pharmacological research

Abd El-Aziz YS, Gillson J, Jansson PJ, Sahni S.
PMID: 34843961
Pharmacol Res. 2021 Nov 27;175:106006. doi: 10.1016/j.phrs.2021.106006. Epub 2021 Nov 27.

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancers which constitutes about 15% of all breast cancer cases and characterized by negative expression of hormonal receptors and human epidermal growth factor receptor 2 (HER2). Thus,...

Cite
Abd El-Aziz YS, Gillson J, Jansson PJ, et al. Autophagy: A promising target for triple negative breast cancers. Pharmacol Res. 2021;175:106006doi: 10.1016/j.phrs.2021.106006.
Abd El-Aziz, Y. S., Gillson, J., Jansson, P. J., & Sahni, S. (2021). Autophagy: A promising target for triple negative breast cancers. Pharmacological research, 175106006. https://doi.org/10.1016/j.phrs.2021.106006
Abd El-Aziz, Yomna S, et al. "Autophagy: A promising target for triple negative breast cancers." Pharmacological research vol. 175 (2021): 106006. doi: https://doi.org/10.1016/j.phrs.2021.106006
Abd El-Aziz YS, Gillson J, Jansson PJ, Sahni S. Autophagy: A promising target for triple negative breast cancers. Pharmacol Res. 2021 Nov 27;175:106006. doi: 10.1016/j.phrs.2021.106006. Epub 2021 Nov 27. PMID: 34843961.
Copy Download .nbib Format: NLM
An overview of the level of dietary support in the gut microbiota at different stages of life: A systematic review.

Clinical nutrition ESPEN

Ribeiro FM, Lopes G, da Cunha Nascimento D, Pires L, Mulder AP, Franco OL, Petriz B.
PMID: 33745615
Clin Nutr ESPEN. 2021 Apr;42:41-52. doi: 10.1016/j.clnesp.2021.01.024. Epub 2021 Feb 09.

BACKGROUND & AIMS: The gut microbiome is an essential factor for the health of the host. Several factors may alter the gut's microbiota composition, including genetic factors, lifestyle, aging, and dietary intervention. This process can be an essential element...

Cite
Ribeiro FM, Lopes G, da Cunha Nascimento D, et al. An overview of the level of dietary support in the gut microbiota at different stages of life: A systematic review. Clin Nutr ESPEN. 2021;42:41-52doi: 10.1016/j.clnesp.2021.01.024.
Ribeiro, F. M., Lopes, G., da Cunha Nascimento, D., Pires, L., Mulder, A. P., Franco, O. L., & Petriz, B. (2021). An overview of the level of dietary support in the gut microbiota at different stages of life: A systematic review. Clinical nutrition ESPEN, 4241-52. https://doi.org/10.1016/j.clnesp.2021.01.024
Ribeiro, Filipe M, et al. "An overview of the level of dietary support in the gut microbiota at different stages of life: A systematic review." Clinical nutrition ESPEN vol. 42 (2021): 41-52. doi: https://doi.org/10.1016/j.clnesp.2021.01.024
Ribeiro FM, Lopes G, da Cunha Nascimento D, Pires L, Mulder AP, Franco OL, Petriz B. An overview of the level of dietary support in the gut microbiota at different stages of life: A systematic review. Clin Nutr ESPEN. 2021 Apr;42:41-52. doi: 10.1016/j.clnesp.2021.01.024. Epub 2021 Feb 09. PMID: 33745615.
Copy Download .nbib Format: NLM
Autophagy: A promising target for triple negative breast cancers.

Pharmacological research

Abd El-Aziz YS, Gillson J, Jansson PJ, Sahni S.
PMID: 34843961
Pharmacol Res. 2022 Jan;175:106006. doi: 10.1016/j.phrs.2021.106006. Epub 2021 Nov 27.

Triple negative breast cancer (TNBC) is the most aggressive type of breast cancers which constitutes about 15% of all breast cancer cases and characterized by negative expression of hormonal receptors and human epidermal growth factor receptor 2 (HER2). Thus,...

Cite
Abd El-Aziz YS, Gillson J, Jansson PJ, et al. Autophagy: A promising target for triple negative breast cancers. Pharmacol Res. 2021;175:106006doi: 10.1016/j.phrs.2021.106006.
Abd El-Aziz, Y. S., Gillson, J., Jansson, P. J., & Sahni, S. (2022). Autophagy: A promising target for triple negative breast cancers. Pharmacological research, 175106006. https://doi.org/10.1016/j.phrs.2021.106006
Abd El-Aziz, Yomna S, et al. "Autophagy: A promising target for triple negative breast cancers." Pharmacological research vol. 175 (2022): 106006. doi: https://doi.org/10.1016/j.phrs.2021.106006
Abd El-Aziz YS, Gillson J, Jansson PJ, Sahni S. Autophagy: A promising target for triple negative breast cancers. Pharmacol Res. 2022 Jan;175:106006. doi: 10.1016/j.phrs.2021.106006. Epub 2021 Nov 27. PMID: 34843961.
Copy Download .nbib Format: NLM
MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study.

Journal of contemporary brachytherapy

Petric P, Hudej R, Music M.
PMID: 27807460
J Contemp Brachytherapy. 2009 Oct;1(3):163-169. Epub 2009 Oct 08.

PURPOSE: To report on preliminary results of a prospective study on MRI-assisted cervix cancer brachytherapy pre-planning.MATERIAL AND METHODS: In six locally advanced cervix cancer patients, five days before the first brachytherapy fraction, tandem & ring applicator was inserted under...

Cite
Petric P, Hudej R, Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachytherapy. 2009;1(3):163-169
Petric, P., Hudej, R., & Music, M. (2009). MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. Journal of contemporary brachytherapy, 1(3), 163-169.
Petric, Primoz, et al. "MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study." Journal of contemporary brachytherapy vol. 1,3 (2009): 163-169.
Petric P, Hudej R, Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachytherapy. 2009 Oct;1(3):163-169. Epub 2009 Oct 08. PMID: 27807460; PMCID: PMC5086485.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 259 entries